Results 181 to 190 of about 55,450 (260)

A Review of Human Immunodeficiency Virus and Hepatitis B Virus Co-Infection in Botswana. [PDF]

Viruses
Mpofu-Dobo L, Lebani K, Blackard JT, Moyo S, Anderson M, Gaseitsiwe S.   +5 more
europepmc   +1 more source

Timely and Efficient Infant Diagnosis Is Required to End AIDS in Children

Journal of the International AIDS Society, Volume 29, Issue S1, June 2026.
ABSTRACT Introduction Though considerable effort and investment has significantly increased the proportion of pregnant women living with HIV accessing lifesaving antiretroviral therapy and lowered the prevalence of vertical HIV transmission, more than 70,000 children die each year due to AIDS‐related deaths, and nearly half of the 1.4 million children ...
Lara Vojnov, Ilesh V. Jani
wiley   +1 more source

Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject Drugs. [PDF]

Open Forum Infect Dis
Tatara E, Shekhtman L, Collier N, Cotler SJ, Mackesy-Amiti ME, Boodram B, Dahari H, Major M, Ozik J.   +8 more
europepmc   +1 more source

Seroprevalence of IgM and IgG Antibodies Directed Against Hepatitis E Virus in 4867 Blood Donors From Tyrol, Austria

Journal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT There may be a risk of transmitting Hepatitis E Virus (HEV) through blood transfusions, however screening blood donors for HEV is not mandatory in Austria. We assessed the seroprevalence of anti–HEV antibodies among blood donors, thereby informing about the risk of HEV‐contaminated blood products.
Lisa Seekircher, Annelies Mühlbacher, Lena Tschiderer, Marco Amato, Manfred Astl, Harald Schennach, Anita Siller, Peter Willeit   +7 more
wiley   +1 more source

National Prevalence and Risk Factors of Hepatitis B Virus Infection in Tunisia Two Decades After Vaccine Introduction. [PDF]

Vaccines (Basel)
Fourati A, Ben Hadj M, Dhaouadi S, Hechaichi A, Letaief H, Safer M, Cherif A, Saffar F, Chelly S, Bouguerra H, Bahrini A, Talmoudi K, Chouki T, Hazgui O, Hannachi N, Bahri O, Bouafif É P Ben Alaya N.   +16 more
europepmc   +1 more source

Beyond Awareness: The Critical Need for Actionable Strategies to Bridge the Knowledge‐Practice Gap in Hepatitis B Prevention

Health Science Reports, Volume 9, Issue 6, June 2026.
Kong Qingfei, Xiao Wen
wiley   +1 more source

Reverse Genetics of Orthoflaviviruses: Strategies for Constructing Functional or Infectious cDNA

Journal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT Reverse genetics (RG) systems have transformed RNA virus research by enabling the recovery of recombinant viruses entirely from cloned cDNA. These platforms allow precise, hypothesis‐driven manipulation of viral genomes and support systematic phenotypic analyses in vitro and in vivo.
Young‐Min Lee
wiley   +1 more source

Plant-based production of virus-like particles from hepatitis C virus. [PDF]

Planta
López-Castillo LM, Gonzalez-Castro R, Sánchez-Segura L, Aguilar-Barragán BA, Lim MAG.   +4 more
europepmc   +1 more source

Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Griffithsin, Brevinin‐2, and CCL20 were identified as potent MERS‐CoV fusion inhibitor candidates targeting the HR2 domain through integrated molecular docking, MD simulations, and MM/PBSA analyses. These peptides demonstrated superior binding stability and favorable safety profiles compared to the standard inhibitor, supporting their potential as ...
Nasser Alotaiq, Doni Dermawan, Samir Chtita   +2 more
wiley   +1 more source

Lipid Nanoparticle-Encapsulated PolyI:C as an Adjuvant Enhances Both Humoral and Cellular Immune Responses to the Hepatitis B Vaccine. [PDF]

Vaccines (Basel)
Zhao Z, Wang B, Wang H, Zhang Q, Liang Y, Liu Y.   +5 more
europepmc   +1 more source